Search

Your search keyword '"Hamilton, Frank"' showing total 129 results

Search Constraints

Start Over You searched for: Author "Hamilton, Frank" Remove constraint Author: "Hamilton, Frank" Publisher elsevier bv Remove constraint Publisher: elsevier bv
129 results on '"Hamilton, Frank"'

Search Results

1. Single cell atlas of human gastric muscle immune cells and macrophage-driven changes in idiopathic gastroparesis

2. Progress in Gastroparesis - A Narrative Review of the Work of the Gastroparesis Clinical Research Consortium

4. 646: GENOME-WIDE ASSOCIATION META-ANALYSIS OF GASTROPARESIS

5. 1073: A SINGLE-CELL SURVEY OF GASTRIC MUSCULARIS MACROPHAGES IN DIABETIC GASTROPARESIS

6. 1155: PATIENTS WITH GASTROPARESIS USING ENTERAL AND/OR PARENTERAL NUTRITION: CLINICAL CHARACTERISTICS AND CLINICAL OUTCOME.

8. 1074: QUANTITATIVE SENSORY TESTING OF ABDOMINAL PAIN RESPONSES: CLINICAL RELEVANCE OF PAIN SENSITIVITY IN GASTROPARESIS

10. Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study

11. Constipation in Patients With Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit

12. Effect of Domperidone Therapy on Gastroparesis Symptoms: Results of a Dynamic Cohort Study by NIDDK Gastroparesis Consortium

13. Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell–Fibroblast Crosstalk

15. Sa394 SYMPTOM CHANGES DURING GASTRIC EMPTYING SCINTIGRAPHY AND WATER LOAD SATIETY TEST IN PATIENTS WITH SYMPTOMS OF GASTROPARESIS: ROLES OF IMPAIRED ACCOMMODATION AND VISCERAL HYPERSENSITIVITY.

16. 865 NEUROPATHIC PAIN CHARACTERISTICS IN GASTROPARESIS: LOSS OF PROTECTIVE SENSATION TO SOMATIC STIMULATION GREATER IN IDIOPATHICS VERSUS DIABETICS

17. Sa385 PREVALENCE AND CLINICAL CHARACTERISTICS OF JOINT HYPERMOBILITY SYNDROME IN PATIENTS WITH GASTROPARESIS AND GASTROPARESIS-LIKE SYMPTOMS.

18. Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features

19. 462 FUNCTIONAL DYSPEPSIA AND GASTROPARESIS ARE INTERCHANGEABLE SYNDROMES WITH COMMON CLINICAL AND PATHOLOGICAL FEATURES

20. 870 REMISSION IN PATIENTS WITH SYMPTOMS OF GASTROPARESIS: PREVALENCE AND PATIENT CHARACTERISTICS.

21. Mo1585 FACTORS ASSOCIATED WITH EFFICACY OF COGNITIVE BEHAVIOR THERAPY VS EDUCATION FOR PATIENTS WITH IRRITABLE BOWEL SYNDROME

22. Su1721 THE FREQUENCY AND CLINICAL IMPLICATIONS OF CHRONIC ABDOMINAL WALL PAIN BASED ON CARNETT'S SIGN TEST IN PATIENTS WITH SYMPTOMS OF GASTROPARESIS

23. Sa1124 SINGLE CELL TRANSCRIPTOMIC APPROACH TO UNDERSTANDING THE GASTRIC MUSCLE IMMUNOME: FEASIBILITY AND FIRST RESULTS SHOWING DISTINCT CLUSTERING AND IMMMUNE DYSREGULATION IN IDIOPATHIC GASTROPARESIS

24. Tu1752 EFFECT OF LIQUID AND SOLID TEST MEALS ON SYMPTOMS AND GASTRIC MYOELECTRICAL ACTIVITY IN PATIENTS WITH CHRONIC UNEXPLAINED NAUSEA AND VOMITING AND NORMAL GASTRIC EMPTYING VERSUS PATIENTS WITH GASTROPARESIS

25. Su1755 CONSTIPATION IN PATIENTS WITH SYMPTOMS OF GASTROPARESIS: A SEVERE SYMPTOM IN A THIRD OF PATIENTS.

26. Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)

27. Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis

28. Aprepitant Has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders

29. Ethnic, Racial, and Sex Differences in Etiology, Symptoms, Treatment, and Symptom Outcomes of Patients With Gastroparesis

30. Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome

31. 432 – Proteomics in Gastroparesis: Unique and Overlapping Protein Signatures in Diabetic and Idiopathic Gastroparesis

33. Mo1592 – Marijuana Use in Patients with Symptoms of Gastroparesis: Prevalence, Patient Characteristics, and Perceived Benefit

34. Tu1613 – Global IBS Symptom Improvement in Cognitive-Behavioral Therapy-Treated Patients is Associated with Clinically Important Changes in Abdominal Pain and Stool Consistency Across All Bowel Types

35. 429 – Autoimmune Antibodies and Symptoms of Autoimmune Disorder in Gastroparesis Patients

37. Mo1591 – Does Other End-Organ Damage Correlate with Risk of Gastroparesis in Diabetics?

38. Mo1589 – Gastric Retention in Gastroparesis: Relationship of Proximal, Distal, and Total Gastric Retention to Symptoms

39. Su1446 – Clinical Characteristics of Patients with Symptoms of Gastroparesis and History of Pancreatitis

40. Mo1590 – Body Weight and Body Weight Changes in Gastroparesis: Relationship to Symptoms of Gastroparesis

41. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome

42. Sa1549 - Effect of Domperidone on Gastroparesis Symptoms: Analysis of Patients Treated with Domperidone in the Niddk Gastroparesis Clinical Research Consortium (Gpcrc) Registry

43. Sa1015 - Ethnic and Racial Differences in Gastroparesis: Relationships with Etiology, Symptoms, and Treatment

44. Sa1548 - Abdominal Pain in Gastroparesis: A Severe Symptom in a Third of Gastroparesis Patients

45. 455 - Durability of the the Effects of Self-Administered Cognitive Behavior Therapy for Patients with Moderate-to-Severe Irritable Bowel Syndrome: 12-Month Follow-up from the IBSOS Trial

46. 143 - Gastric Emptying Changes over Time in Gastroparesis: Comparison of Initial and 48 Week Follow up Gastric Emptying Tests in the Gastroparesis Registry of the Gastroparesis Consortium

47. Su1187 - Clinical and Cost Effectiveness of Minimal-Contact Versus Standard Cognitive Behavior Therapy for Irritable Bowel Syndrome: Results of the IBS Outcome Study (IBSOS)

49. Vitamin D Deficiency in Gastroparesis and Chronic Unexplained Nausea and Vomiting: Relationship with Gastric Emptying and Symptoms

50. Gastric Emptying and Symptoms of Gastroparesis: Specific Symptoms Correlating to Severity of Gastric Retention

Catalog

Books, media, physical & digital resources